General

Ocular ExaminationContact LensesOptionsKnowledge

No CPD Points


In this edition of Advances in Eyecare we hear from three experts about developments in maintaining ocular health. The speakers discuss their fields of research as applicable to optometric practice.

Dr Nicole Carnt outlines the nature of Acanthamoeba keratitis, its causes, diagnosis, management and avoidance. There is some discussion of why there has been an increase in incidence in some UK areas in the last year.

Prof Niall Strang looks at the latest views on the use of low-dose atropine in the slowing of myopic progression and the likely potential this may have for the future for UK-based practitioners in myopia therapy.

Dr Tariq Aslam looks at the review of the Royal College of Ophthalmologists (RCO) guidelines for the screening for retinal disease due to the systemic use of chloroquine and hydroxychloroquine and how the optometrist may be usefully involved in the multidisciplinary approach to future screening and monitoring.

Last published: December 2019

    ◄Unit 2 - Low-dose Atropine (~8 mins)More information►

    Unit 3 - Chloroquine and Hydroxychloroquine Retinopathy Screening (~16 mins)

    Unit 3 - Chloroquine and Hydroxychloroquine Retinopathy Screening (~16 mins)

    Dr Sharon Blackford and Dr Tariq Aslam

    In 2018, the RCO released new guidelines on screening for hydroxychloroquine and chloroquine retinopathy. This was in response to an increase in the use of the drugs, drugs that for a long time have been known to have significant ocular side effects. The new guidelines make specific recommendations on the techniques and timing of baseline and follow-up screening tests. To understand the importance of these drugs, dermatologist Dr Sharon Blackford provides a background summary on their clinical use. Following this, ophthalmologist Dr Tariq Aslam explains the new guidelines and how they will work in practice.

    ◄Unit 2 - Low-dose Atropine (~8 mins)More information►